Fred Busch, MD, is a clinical professor of psychiatry at Weill Cornell Medical College and a faculty member of the Columbia University Center for Psychoanalytic Training and Research. His writing and research have focused on the links between psychoanalysis and psychiatry, including psychodynamic approaches to specific disorders, psychoanalytic research, and psychoanalysis and medication. He has co-authored five books on the psychoanalytic approaches to specific disorders, including Manual of Panic Focused Psychodynamic Psychotherapy, Psychodynamic Treatment of Depression (second edition), Psychodynamic Approaches to the Adolescent with Panic Disorder, Panic Focused Psychodynamic Psychotherapy, eXtended Range, and Trauma Focused Psychodynamic Psychotherapy. He is the sole author of Psychodynamic Approaches to Behavioral Change and Problem-Focused Psychodynamic Psychotherapy. Additionally, he co-authored the book Psychotherapy and Medication: The Challenge of Integration. He has written on integrating biological and psychological/emotional models for panic disorder and trauma. He has been involved in research on panic focused psychodynamic psychotherapy and psychodynamic treatment of posttraumatic stress disorder. His efforts have included the development of treatments, training of therapists and treatment of patients in several studies. These studies led to the first psychodynamic treatment of a DSM anxiety disorders to demonstrate efficacy, panic focused psychodynamic psychotherapy. He has received numerous awards for his teaching, clinical work, and research from the American Psychoanalytic Association, the Payne Whitney Clinic (Weill Cornell Medical College) and the Columbia University Center for Psychoanalytic Training and Research.

Austen Riggs Center Inc. adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. All those at Austen Riggs Center involved in the planning of this activity, including the presenter(s) listed above, report they have no relevant financial relationships with an ineligible company*.

The views and opinions expressed in this presentation are those of the presenter(s) and do not necessarily represent the official policy or position of the Austen Riggs Center.

* An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.